US Stock MarketDetailed Quotes
MYCOF Mydecine Innovations
- 0.007850
- +0.003650+86.90%
15min DelayClose Dec 11 16:00 ET
484.78KMarket Cap-0.06P/E (TTM)
0.007850High0.006100Low2.31KVolume0.006200Open0.004200Pre Close14.66Turnover0.03%Turnover RatioLossP/E (Static)61.76MShares0.08462052wk High-0.04P/B63.98KFloat Cap0.00010052wk Low--Dividend TTM8.15MShs Float110.000000Historical High--Div YieldTTM41.67%Amplitude0.000100Historical Low0.006000Avg Price1Lot Size
About Mydecine Innovations Company
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Company Profile
SymbolMYCOF
Company NameMydecine Innovations
Founded2013
MarketPink Market
Employees3
Fiscal Year Ends12-31
Address1075 West Georgia Street,Suite 1890
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6E 3C9
Phone1-604-687-2038
Websitehttp://mydecine.com
Company Executives
- Name
- Position
- Salary
- David Joshua Bartch
- Director and Chief Executive Officer
- --
- Dean Ditto
- Chief Financial Officer
- --
- Damon Michaels
- Director and Chief Operating Officer
- --
- Robert Roscow
- Director and Chief Scientific Officer
- --
- Dr. Rakesh Jetly
- Chief Medical Officer
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
